drugset / Trial / NCT00478504

Letrozole Versus Clomifene Citrate for Ovulation Induction

NCT00478504

RandomizedCrossoverQuadruple-blindTreatment

Summary

The primary aim of the study is to assess the efficacy of letrozole as an ovulation induction agent and to test the hypothesis that letrozole will generate better pregnancy rates with fewer multiple pregnancies and higher live birth rate than the current standard agent, clomifene citrate in anovular infertile women with polycystic ovarian syndrome.

Timeline

Start
2007-05
Primary completion
2014-06
Completion
2014-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Clomiphene Other / unclassified 100 mg
Comparator Letrozole Other / unclassified 5 mg